Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.16 SEK | -2.87% | +7.94% | +118.16% |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 | |
Sales & Marketing | 62 | 19-01-07 | |
Annica Magnusson
LAW | General Counsel | 61 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Chairman | 64 | 22-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,407,452 | 19,288,290 ( 67.90 %) | 445,974 ( 1.570 %) | 67.90 % |
Company contact information
Moberg Pharma AB
Gustavslundsvägen 50 5th Floor
167 51, Bromma
+46 8 52 23 07 00
http://www.mobergderma.seGroup companies
Name | Category and Sector |
---|---|
Moberg Derma Incentives AB
| |
Pharmaceuticals: Major
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+118.16% | 84.57M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- MOB Stock
- Company Moberg Pharma AB